Advertisement
U.S. markets closed

Stereotaxis, Inc. (STXS)

NYSE American - NYSE American Delayed Price. Currency in USD
2.7100-0.2000 (-6.87%)
At close: 04:00PM EDT
2.6700 -0.04 (-1.48%)
After hours: 05:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close2.9100
Open2.9000
Bid2.6900 x 900
Ask3.0700 x 800
Day's Range2.5800 - 2.9538
52 Week Range1.3300 - 3.2900
Volume405,097
Avg. Volume312,851
Market Cap222.569M
Beta (5Y Monthly)1.34
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for STXS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Stereotaxis, Inc.
    EW: Lowering target price to $98.00EDWARDS LIFESCIENCES CORP has an Investment Rating of HOLD; a target price of $98.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Zacks

    Stereotaxis (STXS) Seeks Clearance for MAGiC Catheter

    Stereotaxis (STXS) announces the regulatory submissions of its MAGiC catheter in Europe and the United States, which are intended for use in minimally invasive cardiac ablation treatments.

  • Insider Monkey

    Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript

    Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript March 4, 2024 Stereotaxis, Inc. reports earnings inline with expectations. Reported EPS is $-0.07 EPS, expectations were $-0.07. STXS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. Thank you for […]

  • Thomson Reuters StreetEvents

    Q4 2023 Stereotaxis Inc Earnings Call

    Q4 2023 Stereotaxis Inc Earnings Call